Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case report

INTRODUCTION: The development of factor VIII inhibitors is a serious complication of replacement therapy in patients with congenital hemophilia A. Immune tolerance induction has been accepted as the only clinically proven treatment allowing antigen-specific tolerance to factor VIII. However, some of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubisz, Peter, Plamenova, Ivana, Holly, Pavol, Stasko, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492051/
https://www.ncbi.nlm.nih.gov/pubmed/23057781
http://dx.doi.org/10.1186/1752-1947-6-350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492051/
https://www.ncbi.nlm.nih.gov/pubmed/23057781
http://dx.doi.org/10.1186/1752-1947-6-350

Ejemplares similares